99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: A correlative study

Journal of Nuclear Medicine

Volumn 40, Issue 4, 1999, Pages 522-529

  Rodriguez, Guido ^a   Nobili, Flavio ^b   Copello, Francesco ^b   Vitali, Paolo ^b   Gianelli, Maria V ^b   Taddei, Gioconda ^b   Catsafados, Elie ^b   Mariani, Giuliano ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

99mTc hexamethyl propyleneamine oxime SPECT; Alzheimer's disease; Quantitative electroencephalogram

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CORRELATION FUNCTION; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; BRAIN CIRCULATION; ELECTROENCEPHALOGRAPHY; FACTORIAL ANALYSIS; METHODOLOGY; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032588554     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Joannesson G, Brun A, Gustafson I, Ingvar DH. EEG in presenile dementia related to cerebral blood flow and autopsy findings. Acta Neurol Scand. 1977;56:89-103.
2. Sheridan PH, Sato S, Foster N, et al. Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry. Neurology. 1988;38:747-750.
3. Ihl R, Eilles C, Frolich L, Maurer K, Dierks T, Persic I. Electrical brain activity and cerebral blood flow in dementia of the Alzheimer type. Psychiatry Res. 1989;29:449-452.
4. Celsis P, Agniel A, Le Tinnier A, et al. Lateral asymmetries in primary degenerative dementia of the Alzheimer type. A correlative study of cognitive, hemodynamic and EEG data, in relation with severity, age of onset and sex. Cortex. 1990;26:585-596.
5. Szelies B, Grond M, Herholz K, Kessler J, Wullen T, Heiss WD. Quantitative EEG mapping and PET in Alzheimer's disease. J Neurol Sci. 1992;110:46-56.
6. Sloan EP, Fenton GW, Kennedy NSJ, MacLennan JM. Electroencephalography and single photon emission computed tomography in dementia: a comparative study. Psychol Med. 1995;25:631-638.
7. Passero S, Rocchi R, Vatti G, Burgalassi L, Baltistini N. Quantitative EEG mapping, regional cerebral blood flow, and neuropsychological function in Alzheimer's disease. Dementia. 1995;6:148-156.
8. Hyman BT, Van Hoesen GW, Damasio AR. Memory-related neural system in Alzheimer's disease: an anatomic study. Neurology. 1990;40:1721-1730.
9. Arriagada PV, Growdon JH, Hedley Whyle ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42:631-639.
10. Ikeda M, Tanabe H, Nakagawa Y, et al. MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease. Neuroradiology. 1994;36:7-10.
11. Steriade M, Gloor P, Llinàs RR, Lopes da Silva FH, Mesulam M-M. Basic mechanisms of cerebral rhythmic activities. Electroenceph Clin Neurophysiol. 1990;76:481-508.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
13. Morris JC, Heyman A, Mohs RC, CERAD Investigators. The consortium to establish a registry for Alzheimer's disease. Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
14. Reisberg B, Ferris SH, De Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-1139.
15. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res. 1975;12:189-198.
16. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1970;9:97-113.
17. Genna S, Smith AP. The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci. 1988;35:654-658.
18. Chang, LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
19. 99mTc-d,l-HMPAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab. 1988;8:S13-S22.
20. Talairach J, Toumoux P. Co-planar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme Medical Publishers, Inc.; 1980.
21. Ohnishi T, Hoshi H, Nagamachi S, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatrie diseases. J Nucl Med. 1995;36:1163-1169.
22. Mountz JM, Deutsch G, Kuzniecky R, et al. Brain SPECT: 1994 update. In: Freemen LM, ed. Nuclear Medicine Annual. New York, NY: Raven Press; 1994:1-54.
23. Buchan RJ, Nagata K, Yokoyama E, et al. Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroenceph Clin Neurophysiol. 1997;103:409-417.
24. Soininen H, Partanen J, Paakkonen A, Koivisto E, Riekkinen PJ. Changes in absolute power values of EEG spectra in the follow-up of Alzheimer's disease. Acta Neurol Scand. 1991;83:133-136.
25. Leuchter AF, Cook IA, Newton TF, et al. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroenceph Clin Neurophysiol. 1993;87:385-393.
26. Strother S, Kanno I, Rottenberg D. Principal component analysis, variance partitioning and "functional connectivity." J Cereb Blood Flow Metab. 1995;15: 353-360.
27. Houston A, Kemp P, MacLeod M. A method for assessing the significance of abnormalities in HMPAO SPECT. J Nucl Med. 1994;35:239-244.
28. Jones K, Johnson KA, Becker A, Spiers PA, Albert MS, Holman BL. Use of singular value decomposition to characterize age and gender differences in SPECT cerebral perfusion. J Nucl Med. 1998;39:965-973.
29. Peskind ER, Leverenz J, Farlow MR, et al. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls. Alzheimer Dis Assoc Disord. 1997;11:201-206.
30. Cureton EE, Mulaik SA. The weighted varimax rotation and the promax rotation. Psychometrika. 1975;40:183-195.
31. Bagley CR. Factor structure of temperament in the third year of life. J Gen Psychol. 1991;11:291-297.
32. Ramsay MC, Reynolds CR. Separate digits tests: a brief history, a literature review, and a reexamination of the factor structure of the test of memory and learning (TOMAL), Neuropsychol Rev. 1995;5:151-171.
33. Craighead WE, Evans DD. Factor analysis of the Montgomery-Asberg depression rating scale. Depression. 1996;4:31-33.
34. Morrison DF. Multivariate Statistical Methods. 2nd ed. New York, NY: McGraw-Hill Book Co.; 1976.
35. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford, UK: Blackwell Scientific Publications; 1987:327-333.
36. Boles DB. Relationships among multiple task asymmetries. Brain Cogn. 1998;36: 268-289.
37. Strite D, Massman PJ, Cooke N, Doody RS. Neuropsychological asymmetries in Alzheimer's disease: verbal versus visuoconstructional deficits across stages of dementia. J Int Neuropsychol Soc. 1997;3:420-427.
38. Messa C, Fazio F, Costa DC, Ell PJ. Clinical brain radionuclide imaging studies. Semin Nucl Med. 1995;25:111-143.
39. Rosadini G, Cogorno P, Marenco S, Nobili F, Rodriguez G. Brain functional imaging in senile psychopathology. Int J Psychophysiol. 1991;10:271-280.
40. Signorino M, Pucci E, Belardinelli N, Nolfe G, Angeleri F. EEG spectral analysis in vascular and Alzheimer dementia. Electroenceph Clin Neurophysiol. 1995;94: 313-325.
41. Brenner RP, Ulrich RF, Spiker DG, et al. Computerized EEG spectral analysis in elderly normal, demented and depressed subjects. Electroenceph Clin Neurophysiol. 1986;64:483-492.
42. Primavera A, Novello P, Finocchi C, Canevari E, Corsello L. Correlation between Mini-Mental State Examination and quantitative electroencephalography in senile dementia of Alzheimer type. Neuropsychobiol. 1990;23:74-78.
43. Szelies B, Grond M, Hcrholz K, Heiss W-D. Functional disturbance in Alzheimer's dementia: EEG power mapping versus PET of glucose metabolism [abstract]. J Cereb Blood Flow Metab. 1991;11(suppl):S169.
44. Arnolds DEAT, Lopes da Silva FH, Aitink JW, Kamp A, Boeijinga P. The spectral properties of hippocampal EEG related to behavior in man. Electroenceph Clin Neurphysiol. 1980;50:324-328.
45. Schreiter-Gasser U, Gasser Th, Ziegler P. Quantitative EEG-analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristes, visual EEG and CCT. Electroenceph Clin Neurophysiol. 1994;90:267-272.
46. Muller TJ, Strik WK, Thome J, et al. Comparative studies in Alzheimer's disease: electroencephalographic brain mapping, HMPAO-SPECT and psychometric tests [abstract]. Hum Brain Mapping. 1995;1(suppl):392.
47. Blauenstein UW, Halsey JS, Wilson EM, Wills EL, Risberg J. 133-xenon method, analysis of reproducibility: some of its physiological implications. Stroke. 1977;8:92-102.
48. Deutsch G, Tweedy J. Cerebral blood flow in severity-matched Alzheimer and multi-infarct patients. Neurology. 1987;37:431-438.
49. Perani D, Di Piero V, Vallar G, et al. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med. 1988;29: 1507-1514.
50. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1992;55:1182-1187.
51. Stefoski D, Bergen D, Fox J, Morrell F, Huckman M, Ramsey R. Correlation between diffuse EEG abnormalities and cerebral atrophy in senile dementia. J Neurol Neurosurg Psychiatry. 1976;39:751-755.
52. Small GW, Kuhl DE, Riege WH, et al. Cerebral glucose metabolic patterns in Alzheimer's disease. Arch Gen Psychiatry. 1989;46:527-532.
53. Schreiter-Gasser U, Gasser Th, Ziegler P. Quantitative EEG-analysis in early onset Alzheimer's disease: a controlled study. Electroenceph Clin Neurophysiol. 1993;86:15-22.
54. d'Onofrio F, Salvia S, Petretta V, Bonavita V, Rodriguez G, Tedeschi G. Quantified EEG in normal aging and dementias. Acta Neurol Scand. 1996;93:336-345.
55. Jagust WJ, Reed BR, Seab JP, Budinger TF. Alzheimer's disease. Age of onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. Arch Neurol. 1990;47:628-633.
56. Duffy FH, Albert MS, McAnulty GB. Brain electrical activity in patients with presenile and senile dementia of Alzheimer's type. Ann Neurol. 1984;16:439-448.
57. Rodriguez G, Nobili F, Rocca G, De Carli F, Gianelli MV, Rosadini G Quantitative electroencephalography and regional cerebral blood flow: discriminant analysis between Alzheimer's patients and healthy controls. Dementia Geriatr Cogn Disord. 1998;9:274-283.
58. Rodriguez G, Nobili F, Arrigo A, et al. Prognostic significance of quantitative electroencephalography in Alzheimer patients: preliminary observations. Electroenceph Clin Neurophysiol. 1996;99:123-128.
59. Moossy J, Zubenko GS, Martinez AJ, Rao GR, Kopp U, Hanin I. Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease. Arch Neurol. 1989;46:639-642.
60. Galaburda AM. Asymmetries of cerebral neuroanatomy. Ciba Fund Symp. 1991;162:219-233.
61. Tohgi H, Takahashi S, Kato E, et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett. 1997;236:21-24.
62. Hunter R, Wyper DJ, Patterson J, Hansen MT, Goodwin GM. Cerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computerised tomography. Br J Psychiatry. 1991;158:351-357.
63. van Dyck CH, Lin CH, Robinson R, et al. The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease. Psychopharmacology. 1997;132:217-226.
64. Siegfried KR. Pharmacodynamic and early clinical studies with velnacrine. Acta Neurol Scand. 1993;149(suppl):26-28.
65. Lapchak PA. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp Neurol. 1993;124: 16-20.
66. Riekkinen P Jr, Riekkinen M, Fisher A, Ekonsalo T, Sirvio J. Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves. Eur J Pharmacol. 1993;10:240:1-7.
67. Duffy FH, McAnulty G, Albert M, Durwen H, Weintraub S. Lecithin: absence of neurophysiologic effect in Alzheimer's disease by EEG topography. Neurology. 1987;37:1015-1019.
68. 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry. 1998;64:306-313.
69. Lawrence AD, Sahakian BJ. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems. Neurochem Res. 1998;23:787-794.
70. Parra P, Gulyas AI, Miles R. How many subtypes of inhibitory cells in the hippocampus? Neuron. 1998;20:983-993.